Drug Shortage Report for HAVRIX 1440

Last updated on 2024-02-22

Report ID 209700
Drug Identification Number 02187078
Brand name HAVRIX - SUS IM 1440 ELISA UNITS/ML
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 1440UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie)
Anatomical Therapeutical Chemical (ATC) code J07BC
Anatomical Therapeutical Chemical (ATC) description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-11-06
Estimated end date 2024-02-26
Actual end date 2024-02-21
Shortage status Resolved
Updated date 2024-02-22
Company comments Supply available for public programs. Supply unavailable in the private market.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-02-22 English Compare
v9 2024-02-21 French Compare
v8 2024-02-21 English Compare
v7 2024-02-16 French Compare
v6 2024-02-16 English Compare
v5 2024-01-10 French Compare
v4 2024-01-10 English Compare
v3 2023-11-10 French Compare
v2 2023-11-10 English Compare
v1 2023-11-10 English Compare

Showing 1 to 10 of 10